Successfully merged with PharmAthene, Inc. • Now trading as ALT
SPAC Overview
$72M
IPO Size
$65M
Trust Amount
Completed
Current Status
2005
IPO Year
Timeline Progress
About
Healthcare Acquisition Corp. is a blank-check company seeking to acquire an unidentified operating business or assets in the healthcare industry through a business combination.
Investment Focus
Healthcare
The terms and the filing trail behind HEALTHCARE ACQUISITION CORP
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Derace L. Schaffer M.D
Chief Executive Officer, Director, Vice-Chairman
John Pappajohn
Chairman of the Board of Directors, Secretary
Mitchel Sayare Ph.D.
Executive Chairman of the Board of Directors
William Enright
Chief Executive Officer, Director, President
Matthew P. Kinley
Director, President, Treasurer
William Michael Brown
Acting Chief Financial Officer
David J. Drutz M.D.
Director
Edward B. Berger
Director
John M. Gill
Director
Klaus Schafer
Director
Philip Hodges
Director
Wayne A. Schellhammer
Director
Elizabeth A. Czerepak
Beneficial owner
Sybil Tasker
Beneficial owner
Wayne Pisano
Beneficial owner
Underwriters
Extended Team Information
The team includes experienced healthcare private-equity investors and company builders John Pappajohn and Derace L. Schaffer, along with Matthew P. Kinley, who has experience financing and developing companies; their work has included numerous healthcare businesses and public-company directorships.
Stock Performance
ALT
Trading Symbol
First Trade
May 26, 2017
$4.50
6 Months Post-Merger
May 26, 2017
$4.44
0%
1 Year Post-Merger
May 26, 2017
$4.44
0%
2 Years Post-Merger
May 26, 2017
$4.44
0%
Current Price
October 2, 2026
$2.73
-39%
Key Information
IPO Date
July 29, 2005
State of Incorporation
DE
SIC
6770
Completion Date
August 3, 2007
Merger Target
PharmAthene, Inc.
SPAC Ticker
HAQ
Merged Ticker
ALT